Results Patient Disposition and Baseline Characteristics In total, 2836 patients receiving oral semaglutide 14 mg/flexibly dosed or comparators were included in the background medication subgroup analyses, and 365 patients receiving oral semaglutide 14 mg or placebo in PIONEER 8 were included in the insulin regimen subgroup analysis
Investigations, audits, and enforcement actions can consume significant time and resources
Approximately 5,000 people participated in the study, and they had a mean age of 46.2 to 55.3 years and were mostly female
If a patient is deficient or following a reduced-calorie plan, consistent support may make more sense than occasional use
Discuss the best timing for taking your oral medications with your healthcare provider
Peptides are short chains of amino acids, or small proteins, which our bodies naturally produce